AIIMS to investigate diabetes in pregnant women
Advertisement
The All India Institute of Medical Sciences (AIIMS) in Delhi in association with The George Institute for Global Health is hoping to reduce the burden of acquiring gestational diabetes mellitus (GDM).
As per a recent report in the Hindu, the partnership hopes to initiate a research to understand in principal if a lifestyle modification program can delay the onset of Type 2 diabetes in women with gestational diabetes mellitus (GDM) in South Asia. The initial random trial has a single-fold purpose of making the treatment available and affordable in countries such as Bangladesh, Sri Lanka and India.
GDM is diabetes that develops during pregnancy, and requires lifelong treatment as it can lead to further serious complications, subsequently putting women at high risk of type 2 diabetes. The low middle-income countries already suffer from a high concentration of people suffering from Type 2 diabetes; thus making it almost essential to make the program available for treatment in such countries.
Under the auspices of the Global Alliance for Chronic Diseases (GACD), the Indian arm of the research is being supported by the Indian Council of Medical Research (ICMR), while the Australian National Health and Medical Research Council is funding the research in Sri Lanka and Bangladesh.
As per a recent report in the Hindu, the partnership hopes to initiate a research to understand in principal if a lifestyle modification program can delay the onset of Type 2 diabetes in women with gestational diabetes mellitus (GDM) in South Asia. The initial random trial has a single-fold purpose of making the treatment available and affordable in countries such as Bangladesh, Sri Lanka and India.
GDM is diabetes that develops during pregnancy, and requires lifelong treatment as it can lead to further serious complications, subsequently putting women at high risk of type 2 diabetes. The low middle-income countries already suffer from a high concentration of people suffering from Type 2 diabetes; thus making it almost essential to make the program available for treatment in such countries.
Under the auspices of the Global Alliance for Chronic Diseases (GACD), the Indian arm of the research is being supported by the Indian Council of Medical Research (ICMR), while the Australian National Health and Medical Research Council is funding the research in Sri Lanka and Bangladesh.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.